UnitedHealth Group says the Justice Department’s antitrust challenge to its proposed $3.3 billion purchase of Amedisys is wrong on the merits and threatens to deprive consumers of benefits from ...
Two whistleblowers have adequately alleged that Amedisys Inc. violated the False Claims Act by improperly billing Medicare and other federal health-care programs for home health services, a New York ...
UnitedHealth Group has withdrawn its motion to dismiss the Justice Department’s ongoing antitrust challenge to a proposed ...
UnitedHealth Group said its motion to dismiss the DOJ lawsuit was moot after the agency cited which regions would be impacted ...
UnitedHealth Group Inc. (NYSE: UNH) is dropping its motion to dismiss the U.S. Department of Justice’s (DOJ) antitrust lawsuit regarding the company’s ...
UnitedHealth Group Inc. is withdrawing its motion to dismiss the Justice Department’s lawsuit seeking to block its $3.3 ...
BATON ROUGE, La., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care services, has recognized 47 employees with the ...
As the demand for personalized and effective health care solutions grows, home health care providers are implementing more ...
Stock analysts at Leerink Partnrs raised their FY2026 earnings per share estimates for shares of Amedisys in a research ...
In a report released on January 29, Whit Mayo from Leerink Partners reiterated a Hold rating on Amedisys (AMED – Research Report), with a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback